Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostate Cancer Metastatic × cabazitaxel × Clear all

Phase

Phase 2 3 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostate Cancer Metastatic 1

Interventions

Prednisone 2 enzalutamide 1 cabazitaxel 1 Prednisolone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02485691 2022-05-27

CARD

Sanofi

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡